Tocolytics: Nursing pharmacology

00:00 / 00:00

Notes

TOCOLYTICS
Drug name
Magnesium sulfate
*High Alert Medication*
nifedipine (Procardia)
terbutaline
indomethacin (Indocin)
Class
Electrolyte
Calcium channel blocker
Beta2-agonist
Inhibits production of prostaglandins
Mechanism of action
Decreases the entry of calcium ions into uterine smooth muscle
Decreases calcium availability within uterine smooth muscle cells
Inhibits production of prostaglandins
Indications
Preterm labor
Route(s) of administration
IV
PO
SL
SUBQ
PO
PR
Side effects
Nausea;
Flushing;
Headache;
Toxicity: 
respiratory depression, cardiac arrest, altered LOC, decreased DTRs, pulmonary edema,
Neonatal hypotonia
Hypotension,
Headache,
Dizziness
Tachycardia,
Arrhythmias,
Palpitations,
Hypotension,
Hyperglycemia,
Hypokalemia,
Pulmonary edema,
Fetal tachycardia
Gastritis,
Oligohydramnios,
Premature PDA closure
Contra-indications and cautions
Myasthenia gravis,
Impaired kidney function,
Recent myocardial infarction
Hypotension,
Hemodynamic instability
Heart disease,
Poorly controlled diabetes
Bleeding disorders,
Peptic ulcer disease,
Renal disease,
Gestational age ≥ 32 weeks
Nursing considerations
All tocolytics
  • Client education: purpose of medication is being administered to help delay labor, potential side effects to report, required nursing monitoring
  • Assessment and monitoring: vital signs; SpO2; weight; heart and lung sounds; uterine activity; cervical dilation and effacement; FHR, and variability
  • Notify OB / midwife: indeterminate or abnormal FHR
  • Prepare for intrauterine resuscitation, as needed: IV fluid bolus, lateral positioning, oxygen administration
TOCOLYTICS: NURSING CONSIDERATIONS
ALL TOCOLYTICS
  • Client education: purpose of medication is being administered to help delay labor, potential side effects to report, required nursing monitoring
  • Assessment and monitoring: vital signs; SpO2; weight; heart and lung sounds; uterine activity; cervical dilation and effacement; FHR, and variability
  • Notify OB / midwife: indeterminate or abnormal FHR
  • Prepare for intrauterine resuscitation, as needed: IV fluid bolus, lateral positioning, oxygen administration
DRUG-SPECIFIC CONSIDERATIONS
Magnesium sulfate
Assessments and monitoring
  • Administered by infusion pump; two nurses check dosage and infusion rate
  • Monitor renal function: baseline serum creatinine, indwelling urinary catheter, I&O
  • Baseline and frequent DTR checks
  • Calcium gluconate (antidote) readily available
  • Notify OB / midwife: UO < 30mL/hr; absent DTRs, RR < 12/min, SpO2 < 95%, shortness of breath, adventitious breath sounds, decreased LOC, magnesium level > 8 mg/dL
Nifedipine
Assessments and monitoring
  • Closely monitor for hypotension
Terbutaline
Assessments and monitoring
  • Do not use for > 72 hours
  • Monitor blood glucose
  • Assess the maternal heart rate and the FHR pattern before and after each dose
  • Hold dose and notify OB / midwife for FHR > 180 indeterminate or abnormal FHR; maternal heart rate > 120 beats per minute; palpitations; respirations > 30 breaths per minute,  pulmonary crackles, SpO2 < 95%
Indomethacin
Assessments and monitoring
  • Do not use for > 48 hours of if gestational age is > 32 weeks

Transcript

Watch video only

Tocolytics are a group of medications that suppress uterine contractions. For that reason, tocolytics are typically used to prolong pregnancy and delay birth after preterm labor starts before 34 weeks of gestation. Delaying labor is usually done to transfer the client to a higher health care facility if needed, or to administer medications that improve fetal outcomes, such as corticosteroids, which promote fetal lung maturation.

Now, the most commonly used tocolytics are magnesium sulfate, calcium channel blockers like nifedipine, beta2-agonists like terbutaline, and NSAIDs like indomethacin.

When tocolytics are administered, they cause smooth muscle relaxation in the uterus via various mechanisms. Both magnesium sulfate and calcium channel blockers like nifedipine block calcium channels, which inhibits the entry of calcium ions into uterine smooth muscles and thus decreases their contractility. In addition to its tocolytic effect, magnesium sulfate also has a neuroprotective effect on the preterm brain, which is more susceptible to injury. On the other hand, beta2-agonists bind to beta2-receptors located on the surface of smooth muscle cells, ultimately leading to a decrease in the level of intracellular calcium and decreasing their contractility. Finally, NSAIDs inhibit the enzyme cyclooxygenase, which normally helps to produce prostaglandins. As a result, there’s a decrease in prostaglandin levels, which ultimately results in relaxation of the uterine smooth muscle.

Now, tocolytics can cause several maternal and fetal side effects. Side effects of magnesium sulfate include nausea, flushing, and headache. In addition, magnesium sulfate toxicity can lead to respiratory depression, cardiac arrest, as well as neurological side effects like altered mental status, reduced deep tendon reflexes, and muscle weakness. Now, magnesium sulfate may have side effects on the fetus. As it relaxes the muscles, some babies who are exposed to magnesium can present with hypotonia or low muscle tone. Fortunately, this side effect is not permanent, and usually improves as magnesium sulfate clears from the baby.

Summary

Tocolytics are medications used to inhibit preterm labor or stop contractions in women who are at risk of giving birth prematurely. Tocolytics work by relaxing the uterine muscles, thus delaying the delivery and allowing more time for the fetus to mature and complete pre-delivery medications. Common tocolytic medications include: Magnesium sulfate: It works by reducing the amount of calcium in the uterine muscles, which results in relaxation and decreased contractions. Nifedipine: It works by blocking the calcium channels in the uterine muscle cells, preventing them from contracting. Indomethacin: It works by inhibiting the production of prostaglandins, which normally induce contractions. Terbutaline: A beta-agonist that works by stimulating the beta receptors in the uterus, which results in relaxation and decreased contractions. Patients who are receiving tocolytics should be under close monitoring in health care institutions since severe adverse drug effects can happen and labor can still continue despite treatment.

Sources

  1. "Tocolysis" StatPearls [Internet] (2021)
  2. "Inhibition of acute preterm labor" UpToDate (2020)
  3. "19 - Uterine Contraction Agents and Tocolytics" Academic Press (2013)
  4. "Saunders Comprehensive Review for the NCLEX-RN Examination (8e)" Saunders (2020)
  5. "Pharmacology: A Patient-Centered Nursing Process Approach )8e)" Elsevier Health Sciences (2014)
  6. "Awhonn's Perinatal Nursing" Elsevier Evolve (2020)
  7. "Maternal-Newborn Nursing" F.A. Davis Company (2010)
  8. "Preterm Labor" Medscape (2021)
  9. "Practice Bulletin No. 171: Management of Preterm Labor" American College of Obstetricians and Gynecologists (2016)
  10. "Mosby's 2021 Nursing Drug Reference (34e)" Mosby (2020)